US 10723733
Hepatitis B antiviral agents
granted A61PA61P31/14
Quick answer
US patent 10723733 (Hepatitis B antiviral agents) held by Enanta Pharmaceuticals, Inc. expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P31/14